We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights Thermo Fisher Scientific, Micron Technology, KLA and Moving iMage Technologies
Read MoreHide Full Article
For Immediate Release
Chicago, IL – August 5, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks and ETFs recently featured in the blog include: Thermo Fisher Scientific Inc. (TMO - Free Report) , Micron Technology, Inc. (MU - Free Report) KLA Corp. (KLAC - Free Report) and Moving iMage Technologies, Inc. (MITQ - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Research Reports for Thermo Fisher Scientific, Micron Technology & KLA
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Thermo Fisher Scientific Inc., Micron Technology, Inc. and KLA Corp., as well as micro-cap stock Moving iMage Technologies, Inc. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Thermo Fisher Scientific’s shares have outperformed the Zacks Medical - Instruments industry over the past year (+11.6% vs. +3.7%). The company is braving the ongoing tough economic conditions by utilizing the (Practical Process Improvement) PPI Business System, resulting in strong financial performance.
Thermo Fisher Scientific’s growth strategy is further bolstered by several new product launches, including Stellar Mass Spectrometer and three new build-for-purpose editions of Orbitrap Ascend Tribrid Mass Spectrometer in the second quarter. The consistent efforts to expand bioproduction purification resin capacity, which is used in the mRNA manufacturing process, look encouraging.
The company’s continuous efforts to prioritize its partnership with customers to drive innovation and improve patient care bode well. A strong solvency position is an added advantage. The raised 2024 EPS outlook also instills optimism. However, the year-over-year decline in revenues in Life Science Solution
Shares of Micron Technology have gained +14.1% over the year-to-date period against the Zacks Semiconductor Memory industry’s gain of +19.0%. The company is benefiting from improved market conditions, robust sales executions and strong growth across multiple business units. The positive impact of inventory improvement in the data center, as well as stabilization in other markets, such as automotive, industrial and others, is contributing to top-line growth.
It anticipates the pricing of DRAM and NAND chips to increase next year, thereby improving its revenues. The pricing benefits should primarily be driven by rising AI servers, causing a scarcity in the availability of cutting-edge DRAM and NAND supply.
Also, 5G adoption in the Internet of Things devices and wireless infrastructure is likely to spur demand for memory and storage. However, the United States and China’s tit-for-tat trade war is a major threat to the company.
KLA’s shares have outperformed the Zacks Electronics - Miscellaneous Products industry over the year-to-date period (+23.8% vs. +4.1%). The company is benefiting from the strong performance of the wafer inspection business owing to rising demand for advanced wafer inspection applications in leading-edge technology development.
KLA is benefiting from the higher volume of wafer manufacturing, more complex designs, larger die and chip size driven by strong AI adoption. Increasing advanced packaging demands which support an increase in process control intensity bodes well for KLA.
Growing investments across multiple nodes and rising capital intensity in Foundry & Logic are driving the top-line growth. KLA's emphasis on the integration of AI into its solutions has driven its outperformance in the semiconductor market.
However, weakness in the PCB, Display and Component Inspection remains a headwind. Softness in memory and leading-edge, logic and foundry investments has been a concern.
Shares of Moving iMage Technologies have underperformed the Zacks Technology Services industry over the past year (-37.4% vs. +29.0%). This microcap company with market capitalization of $6.75 million is winning significant contracts with Alamo Drafthouse Cinema and expansion into high-margin SaaS and subscription-based products like MiTranslator and CineQC promise higher margins and recurring revenues.
Diversifying into live entertainment and esports markets mitigates cinema industry cyclicality. Operating in a growing market, MiT is well-positioned to capitalize on technological advancements and increased demand for high-quality cinema experiences.
Financial stability, as evidenced by $5.9 million in cash, supports growth. However, supply chain disruptions, competition from OTT platforms and regulatory compliance costs pose risks.
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights Thermo Fisher Scientific, Micron Technology, KLA and Moving iMage Technologies
For Immediate Release
Chicago, IL – August 5, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks and ETFs recently featured in the blog include: Thermo Fisher Scientific Inc. (TMO - Free Report) , Micron Technology, Inc. (MU - Free Report) KLA Corp. (KLAC - Free Report) and Moving iMage Technologies, Inc. (MITQ - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Research Reports for Thermo Fisher Scientific, Micron Technology & KLA
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Thermo Fisher Scientific Inc., Micron Technology, Inc. and KLA Corp., as well as micro-cap stock Moving iMage Technologies, Inc. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Thermo Fisher Scientific’s shares have outperformed the Zacks Medical - Instruments industry over the past year (+11.6% vs. +3.7%). The company is braving the ongoing tough economic conditions by utilizing the (Practical Process Improvement) PPI Business System, resulting in strong financial performance.
Thermo Fisher Scientific’s growth strategy is further bolstered by several new product launches, including Stellar Mass Spectrometer and three new build-for-purpose editions of Orbitrap Ascend Tribrid Mass Spectrometer in the second quarter. The consistent efforts to expand bioproduction purification resin capacity, which is used in the mRNA manufacturing process, look encouraging.
The company’s continuous efforts to prioritize its partnership with customers to drive innovation and improve patient care bode well. A strong solvency position is an added advantage. The raised 2024 EPS outlook also instills optimism. However, the year-over-year decline in revenues in Life Science Solution
(You can read the full research report on Thermo Fisher Scientfic here >>>)
Shares of Micron Technology have gained +14.1% over the year-to-date period against the Zacks Semiconductor Memory industry’s gain of +19.0%. The company is benefiting from improved market conditions, robust sales executions and strong growth across multiple business units. The positive impact of inventory improvement in the data center, as well as stabilization in other markets, such as automotive, industrial and others, is contributing to top-line growth.
It anticipates the pricing of DRAM and NAND chips to increase next year, thereby improving its revenues. The pricing benefits should primarily be driven by rising AI servers, causing a scarcity in the availability of cutting-edge DRAM and NAND supply.
Also, 5G adoption in the Internet of Things devices and wireless infrastructure is likely to spur demand for memory and storage. However, the United States and China’s tit-for-tat trade war is a major threat to the company.
(You can read the full research report on Micron Technology here >>>)
KLA’s shares have outperformed the Zacks Electronics - Miscellaneous Products industry over the year-to-date period (+23.8% vs. +4.1%). The company is benefiting from the strong performance of the wafer inspection business owing to rising demand for advanced wafer inspection applications in leading-edge technology development.
KLA is benefiting from the higher volume of wafer manufacturing, more complex designs, larger die and chip size driven by strong AI adoption. Increasing advanced packaging demands which support an increase in process control intensity bodes well for KLA.
Growing investments across multiple nodes and rising capital intensity in Foundry & Logic are driving the top-line growth. KLA's emphasis on the integration of AI into its solutions has driven its outperformance in the semiconductor market.
However, weakness in the PCB, Display and Component Inspection remains a headwind. Softness in memory and leading-edge, logic and foundry investments has been a concern.
(You can read the full research report on KLA here >>>)
Shares of Moving iMage Technologies have underperformed the Zacks Technology Services industry over the past year (-37.4% vs. +29.0%). This microcap company with market capitalization of $6.75 million is winning significant contracts with Alamo Drafthouse Cinema and expansion into high-margin SaaS and subscription-based products like MiTranslator and CineQC promise higher margins and recurring revenues.
Diversifying into live entertainment and esports markets mitigates cinema industry cyclicality. Operating in a growing market, MiT is well-positioned to capitalize on technological advancements and increased demand for high-quality cinema experiences.
Financial stability, as evidenced by $5.9 million in cash, supports growth. However, supply chain disruptions, competition from OTT platforms and regulatory compliance costs pose risks.
(You can read the full research report on Moving iMage Technologies here >>>)
Why Haven’t You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.